About Us

1:
High-dose selenium for the mitigation of radiation injury: a pilot study in a rat model.
Sieber F, Muir SA, Cohen EP, North PE, Fish BL, Irving AA, Mäder M, Moulder JE.
Radiat Res. 2009 Mar;171(3):368-73.
PMID: 19267564

2:
Chronic oxidative stress as a mechanism for radiation nephropathy.
Lenarczyk M, Cohen EP, Fish BL, Irving AA, Sharma M, Driscoll CD, Moulder JE.
Radiat Res. 2009 Feb;171(2):164-72.
PMID: 19267541

3:
Structural and functional alterations in the rat lung following whole thoracic irradiation with moderate doses: injury and recovery.
Zhang R, Ghosh SN, Zhu D, North PE, Fish BL, Morrow NV, Lowry T, Nanchal R, Jacobs ER, Moulder JE, Medhora M.
Int J Radiat Biol. 2008 Jun;84(6):487-97.
PMID: 18470747

4:
Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial.
Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, Juckett MB, Moulder JE.
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1546-51. Epub 2007 Oct 29.
PMID: 18029109

5:
Role of the angiotensin II type-2 receptor in radiation nephropathy.
Cohen EP, Fish BL, Sharma M, Li XA, Moulder JE.
Transl Res. 2007 Aug;150(2):106-15. Epub 2007 May 25.
PMID: 17656330

6:
Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists.
Moulder JE, Fish BL, Cohen EP.
Curr Pharm Des. 2007;13(13):1317-25. Review.
PMID: 17506717

7:
Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis.
Molteni A, Wolfe LF, Ward WF, Ts'ao CH, Molteni LB, Veno P, Fish BL, Taylor JM, Quintanilla N, Herndon B, Moulder JE.
Curr Pharm Des. 2007;13(13):1307-16.
PMID: 17506716

8:
Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury.
Moulder JE, Cohen EP.
Semin Radiat Oncol. 2007 Apr;17(2):141-8. Review.
PMID: 17395044

9:
Significant increase in end-stage renal disease after hematopoietic stem cell transplantation.
Cohen EP, Drobyski WR, Moulder JE.
Bone Marrow Transplant. 2007 May;39(9):571-2. Epub 2007 Mar 12. No abstract available.
PMID: 17351643

10:
Renal dysfunction after total body irradiation: dose-effect relationship: in regard to Kal and van Kempen-Harteveld (Int J Radiat Oncol Biol Phys 2006;65:1228-1232).
Moulder JE, Cohen EP.
Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):319; author reply 319-20. No abstract available.
PMID: 17189082

11:
Potential deployment of angiotensin I converting enzyme inhibitors and of angiotensin II type 1 and type 2 receptor blockers in cancer chemotherapy.
Molteni A, Heffelfinger S, Moulder JE, Uhal B, Castellani WJ.
Anticancer Agents Med Chem. 2006 Sep;6(5):451-60. Review.
PMID: 17017854

12:
Arachidonic acid metabolites mediate the radiation-induced increase in glomerular albumin permeability.
Sharma M, McCarthy ET, Sharma R, Fish BL, Savin VJ, Cohen EP, Moulder JE.
Exp Biol Med (Maywood). 2006 Jan;231(1):99-106.
PMID: 16380650

13:
Radiation induces endothelial dysfunction in murine intestinal arterioles via enhanced production of reactive oxygen species.
Hatoum OA, Otterson MF, Kopelman D, Miura H, Sukhotnik I, Larsen BT, Selle RM, Moulder JE, Gutterman DD.
Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):287-94.
PMID: 16322529

14:
Radiation-induced skin injury in the animal model of scleroderma: implications for post-radiotherapy fibrosis.
Kumar S, Kolozsvary A, Kohl R, Lu M, Brown S, Kim JH.
Radiat Oncol. 2008 Nov 24;3:40.
PMID: 19025617

15:
Mitigation of radiation-induced skin injury by AAV2-mediated MnSOD gene therapy.
Yan S, Brown SL, Kolozsvary A, Freytag SO, Lu M, Kim JH.
J Gene Med. 2008 Sep;10(9):1012-8.
PMID: 18613255

16:
Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice.
Brown SL, Kolozsvary A, Liu J, Ryu S, Kim JH.
Radiat Res. 2008 Apr;169(4):474-8.
PMID: 18363436

17:
Mechanisms of radiation-induced brain toxicity and implications for future clinical trials.
Kim JH, Brown SL, Jenrow KA, Ryu S.
J Neurooncol. 2008 May;87(3):279-86. Epub 2008 Jan 22. Review.
PMID: 18209952

18:
Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor.
Kohl RR, Kolozsvary A, Brown SL, Zhu G, Kim JH.
Radiat Res. 2007 Oct;168(4):440-5.
PMID: 17903031

19:
Mitigation of radiation-induced optic neuropathy in rats by ACE inhibitor ramipril: importance of ramipril dose and treatment time.
Ryu S, Kolozsvary A, Jenrow KA, Brown SL, Kim JH.
J Neurooncol. 2007 Apr;82(2):119-24. Epub 2006 Sep 27.
PMID: 17004100